Works about NEUROTRANSMITTER uptake inhibitors

Results: 1139

Association of Language Preference with Therapeutic Care for Hospitalized COVID-19 Patients.

Published in:

Journal of Racial & Ethnic Health Disparities, 2025, v. 12, n. 4, p. 2454, doi. 10.1007/s40615-024-02065-2

By:

Quadri, Nasreen S.;
Martins, Summer L.;
Sidebottom, Abbey;
Mohamed, Samira;
Ha, Ngoc;
Nguyen, Duc;
Patel, Love;
Kethireddy, Rajesh

Publication type:

Article

JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 4, p. 525, doi. 10.1007/s40257-025-00946-8

By:

Iorizzo, Matilde;
Sechi, Andrea;
Neubauer, Zachary J. K.;
Zhou, Maggie;
Lipner, Shari R.

Publication type:

Article

Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 4, p. 611, doi. 10.1007/s40257-025-00932-0

By:

King, Brett;
Mostaghimi, Arash;
Shimomura, Yutaka;
Piraccini, Bianca Maria;
Blume-Peytavi, Ulrike;
Sontag, Angelina;
Dutronc, Yves;
Denning, Karen;
Kolodsick, Jill;
Lu, Xiaoyu;
Srivastava, Ayush;
Sinclair, Rodney

Publication type:

Article

Recent Advances in Management of Vitiligo.

Published in:

Indian Journal of Dermatology, 2025, v. 70, n. 4, p. 201, doi. 10.4103/ijd.ijd_158_25

By:

Das, Kinnor;
Sarkar, Rashmi;
Sinha, Surabhi

Publication type:

Article

Spinal cord stimulation in the management of painful diabetic sensorimotor peripheral neuropathy.

Published in:

Journal of Diabetes Nursing, 2022, v. 26, n. 3, p. 1

By:

Lalkhen, Abdul-Ghaaliq

Publication type:

Article

Spinal cord stimulation in the management of painful diabetic sensorimotor peripheral neuropathy.

Published in:

Journal of Diabetes Nursing, 2022, v. 26, n. 2, p. 1

By:

Lalkhen, Abdul-Ghaaliq

Publication type:

Article

A Comparison of Reboxetine and Amitryptilline in the Treatment of Fibromyalgia Syndrome with Co-morbid Depressive Symptoms: An Open-label Preliminary Study.

Published in:

Klinik Psikofarmakoloji Bulteni, 2010, v. 20, n. 1, p. 29, doi. 10.1080/10177833.2010.11790631

By:

Konuk, Numan;
Ortancil, Ozgur;
Bostanci, Bora;
Kiran, Sibel;
Sapmaz, Perihan

Publication type:

Article

Erken Boşalma, Tedavisi ve Selektif Serotonin Gerialım İnhibitörlerinin Etkinliği.

Published in:

Klinik Psikofarmakoloji Bulteni, 2007, v. 17, n. 2, p. 87

By:

Doğan, Sultan;
Doğan, Mehmet

Publication type:

Article

Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 11, p. 2563, doi. 10.1111/jog.15761

By:

Yunianto, Irfan;
Currie, Margaret;
Chitcholtan, Kenny;
Sykes, Peter

Publication type:

Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 8, p. 9, doi. 10.1002/pu.31056
Publication type:: Article

Review: Combining antidepressants superior to monotherapy in acute depression.

Published in:

Brown University Psychopharmacology Update, 2022, v. 33, n. 6, p. 1, doi. 10.1002/pu.30876

By:

J., Henssler;
D., Alexander;
G., Schwarzer

Publication type:

Article

YOUR MEDICATION INFORMATION.

Published in:: Brown University Psychopharmacology Update, 2018, v. 29, p. 1, doi. 10.1002/pu.30380
Publication type:: Article

The VMAT2 inhibitors: New hope for an old scourge.

Published in:

Brown University Psychopharmacology Update, 2017, v. 28, n. 11, p. 5, doi. 10.1002/pu.30274

By:

Price, Lawrence H.

Publication type:

Article

Use of easily available biomarker could predict antidepressant response.

Published in:: Brown University Psychopharmacology Update, 2014, v. 25, n. 11, p. 1
Publication type:: Article

From the FDA.

Published in:: Brown University Psychopharmacology Update, 2013, v. 24, n. 10, p. 8
Publication type:: Article

SSRI discontinuation syndrome.

Published in:

Postgraduate Medicine, 2003, v. 114, n. 2, p. 79

By:

Ditto, Kara E.

Publication type:

Article

OP020 INHIBITION OF JAK 1/2 AS A POTENTIAL TARGET IN THE TREATMENT OF RECALCITRANT PYODERMA GANGRENOSUM: A CASE REPORT.

Published in:

Journal of Wound Management, 2023, v. 24, n. 2, p. 392

By:

Margiotta, Flavia Manzo;
Michelucci, Alessandra;
Granieri, Giammarco;
Salvia, Giorgia;
Janowska, Agata;
Romanelli, Marco

Publication type:

Article

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

Published in:

Oncologist, 2024, v. 29, n. 4, p. e514, doi. 10.1093/oncolo/oyad338

By:

Piha-Paul, Sarina A;
Xu, Binghe;
Dumbrava, Ecaterina E;
Fu, Siqing;
Karp, Daniel D;
Meric-Bernstam, Funda;
Hong, David S;
Rodon, Jordi A;
Tsimberidou, Apostolia M;
Raghav, Kanwal;
Ajani, Jaffer A;
Conley, Anthony P;
Mott, Frank;
Fan, Ying;
Fan, Jean;
Peng, Peng;
Wang, Hui;
Ni, Shumao;
Sun, Caixia;
Qiang, Xiaoyan

Publication type:

Article

Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease.

Published in:

Oncologist, 2022, v. 27, n. 8, p. 685, doi. 10.1093/oncolo/oyac076

By:

Martini, Dylan J;
Chen, Yi-Bin;
DeFilipp, Zachariah

Publication type:

Article

PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.

Published in:

Oncologist, 2022, v. 27, n. 8, p. e661, doi. 10.1093/oncolo/oyac072

By:

Kaplan, Henry G;
Jin, Ruyun;
Bifulco, Carlo B;
Scanlan, James M;
Corwin, David R

Publication type:

Article

FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 493, doi. 10.1093/oncolo/oyac042

By:

Le, Robert Q;
Wang, Xin;
Zhang, Hongfei;
Li, Hongshan;
Przepiorka, Donna;
Vallejo, Jonathon;
Leong, Ruby;
Ma, Lian;
Goldberg, Kirsten B;
Pazdur, Richard;
Theoret, Marc R;
Claro, Angelo De

Publication type:

Article

Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients.

Published in:

Oncologist, 2021, v. 26, n. 11, p. e2082, doi. 10.1002/onco.13903

By:

Anandappa, Annabelle J.;
Hobbs, Gabriela S.;
Dey, Bimalangshu R.;
El‐Jawahri, Areej;
Frigault, Matthew J.;
McAfee, Steven L.;
O'Donnell, Paul V.;
Spitzer, Thomas R.;
Chen, Yi‐Bin;
DeFilipp, Zachariah

Publication type:

Article

Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.

Published in:

Oncologist, 2021, v. 26, n. 5, p. 406, doi. 10.1002/onco.13769

By:

Tremblay, Douglas;
Rippel, Noa;
Feld, Jonathan;
El Jamal, Siraj M.;
Mascarenhas, John

Publication type:

Article

Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation.

Published in:

Journal of Pediatric Research, 2022, v. 9, n. 2, p. 197, doi. 10.4274/jpr.galenos.2022.69335

By:

Eker, Nurşah;
Taş, Burcu Tufan;
Doğru, Ömer;
Şenay, Emel;
Tokuç, Ayşe Gülnur;
Koç, Ahmet

Publication type:

Article

Therapeutic effects of tofacitinib on pristane-induced murine lupus.

Published in:

Archives of Rheumatology, 2022, v. 37, n. 2, p. 195, doi. 10.46497/ArchRheumatol.2022.8252

By:

Jiayi Lin;
Yaqin Zhang;
Meihua Wang;
Yang Zhang;
Pin Li;
Yingping Cao;
Xuwei Yang

Publication type:

Article

Successful treatment of tofacitinib in a case with rheumatoid arthritis who experienced hepatitis B virus reactivation induced by tocilizumab and recovered from entecavir rescue therapy.

Published in:

Archives of Rheumatology, 2021, v. 36, n. 3, p. 458, doi. 10.46497/ArchRheumatol.2021.8230

By:

Jin-Xian Huang;
Li-Jun Zhang

Publication type:

Article

The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib.

Published in:

Archives of Rheumatology, 2021, v. 36, n. 2, p. 305, doi. 10.46497/ArchRheumatol.2021.8212

By:

Chung-Mao Kao;
Tsu-Yi Hsieh;
Kuo-Lung Lai

Publication type:

Article

Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis.

Published in:

Archives of Rheumatology, 2020, v. 35, n. 3, p. 440, doi. 10.46497/ArchRheumatol.2020.7541

By:

Erol, Kemal;
Ertaş, Ragıp

Publication type:

Article

Atopic dermatitis: new insights into a common condition.

Published in:

British Journal of Community Nursing, 2024, v. 29, n. 10, p. 490, doi. 10.12968/bjcn.2024.0113

By:

Greener, Mark

Publication type:

Article

An injectable acoustic transmitter for juvenile salmon.

Published in:

Scientific Reports, 2015, p. 8111, doi. 10.1038/srep08111

By:

Deng, Z. D.;
Carlson, T. J.;
Li, H.;
Xiao, J.;
Myjak, M. J.;
Lu, J.;
Martinez, J. J.;
Woodley, C. M.;
Weiland, M. A.;
Eppard, M. B.

Publication type:

Article

The era of ESSTIs is slowly approaching?

Published in:

BJU International, 2005, v. 96, n. 1, p. 181, doi. 10.1111/j.1464-410X.2005.05659.x

By:

Wyllie, Michael G.

Publication type:

Article

The effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo study.

Published in:

BJU International, 2001, v. 88, n. 7, p. 771, doi. 10.1046/j.1464-4096.2001.02389.x

By:

Bae, J.H.;
Moon, D.G.;
Lee, J.G.

Publication type:

Article

Medication information for Flemish inpatients with major depression: evaluation and construct validity of the Consumer Information Rating Form.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2009, v. 34, n. 6, p. 645, doi. 10.1111/j.1365-2710.2009.01039.x

By:

Desplenter, F.;
Laekeman, G.;
Demyttenaere, K.;
Simoens, S.

Publication type:

Article

Treatment of panic disorder with bupropion in a patient with Parkinson’s disease.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2008, v. 33, n. 5, p. 575, doi. 10.1111/j.1365-2710.2008.00952.x

By:

Gebhardt, S.;
Röttgers, H.;
Bäcker, A.;
Schu, U.;
Krieg, J.-C.

Publication type:

Article

Effect of MKC-733, a 5-HT<sub>3</sub> receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2005, v. 30, n. 6, p. 611, doi. 10.1111/j.1365-2710.2005.00695.x

By:

Fujita, T.;
Yokota, S.;
Sawada, M.;
Majima, M.;
Ohtani, Y.;
Kumagai, Y.

Publication type:

Article

G-protein coupled receptors: SAR analyses of neurotransmitters and antagonists.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2004, v. 29, n. 3, p. 279, doi. 10.1111/j.1365-2710.2004.00563.x

By:

Kuo, C. L.;
Wang, R. B.;
Shen, L. J.;
Lien, L. L.;
Lien, E. J.

Publication type:

Article

Efficacy of Oral Tofacitinib Monotherapy in Alopecia Totalis and Universalis in Two Asian Males.

Published in:

Apollo Medicine, 2023, v. 20, p. S141, doi. 10.4103/am.am_148_22

By:

Gorai, Surajit;
Khare, Soumil;
Dhurat, Rachita

Publication type:

Article

Systemic Treatments for Atopic Dermatitis in Children and Adolescents: Review of Current Practice and New Treatments.

Published in:

Apollo Medicine, 2023, v. 20, n. 1, p. 61, doi. 10.4103/am.am_210_22

By:

Dodein, Razan;
Abdul-Wahab, Alya;
Banerjee, Piu

Publication type:

Article

Melatonin attenuates dental pulp stem cells senescence due to vitro expansion via inhibiting MMP3.

Published in:

Oral Diseases, 2024, v. 30, n. 4, p. 2410, doi. 10.1111/odi.14649

By:

Zhang, Zeying;
Bao, Yandong;
Wei, Penggong;
Yan, Xiaoyuan;
Qiu, Qiujing;
Qiu, Lihong

Publication type:

Article

The effects induced by the sulphonylurea glibenclamide on the neonatal rat spinal cord indicate a novel mechanism to control neuronal excitability and inhibitory neurotransmission.

Published in:

British Journal of Pharmacology, 2007, v. 150, n. 1, p. 47, doi. 10.1038/sj.bjp.0706943

By:

Ostroumov, K.;
Grandolfo, M.;
Nistri, A.

Publication type:

Article

Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.

Published in:

2005

By:

Vandevoorde, Séverine;
Fowler, Christopher J.;
Vandevoorde, Séverine

Publication type:

journal article

R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter.

Published in:

British Journal of Pharmacology, 2004, v. 142, n. 1, p. 172, doi. 10.1038/sj.bjp.0705738

By:

Stórustovu, Signeí;
Sánchez, Connie;
Pörzgen, Peter;
Brennum, Lise T.;
Larsen, Anna Kirstine;
Pulis, Monica;
Ebert, Bjarke

Publication type:

Article

Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts.

Published in:

British Journal of Pharmacology, 2002, v. 135, n. 8, p. 1927

By:

Vargas, Gricelly;
DeFelice, Louis J.;
Jayanthi, Lankupalle D.

Publication type:

Article

Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1.

Published in:

2002

By:

Sitte, Harald H.;
Singer, Ernst A.;
Scholze, Petra

Publication type:

journal article

Advancing treatment for idiopathic inflammatory myopathies: insights into immune modulation by JAK inhibition.

Published in:

2025

By:

Fujimoto, Manabu;
Ueda-Hayakawa, Ikuko

Publication type:

Editorial

Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis.

Published in:

Rheumatology, 2025, v. 64, n. 6, p. 3434, doi. 10.1093/rheumatology/keaf096

By:

Sendaydiego, Xavier;
Gold, Laura S;
Dubreuil, Maureen;
Andrews, James S;
Reid, Pankti;
Liew, David F L;
Goulabchand, Radjiv;
Hughes, Grant C;
Sparks, Jeffrey A;
Jarvik, Jeffrey G;
Singh, Siddharth;
Liew, Jean W;
Singh, Namrata

Publication type:

Article

Experience with upadacitinib in refractory polyarticular juvenile idiopathic arthritis.

Published in:

Rheumatology, 2025, v. 64, n. 6, p. 4078, doi. 10.1093/rheumatology/keaf085

By:

Uçar, Sıla Atamyıldız;
Tunce, Eray;
Sözeri, Betül

Publication type:

Article

Tofacitinib treatment for active dermatomyositis and anti-synthetase syndrome: a prospective cohort pilot study.

Published in:

Rheumatology, 2025, v. 64, n. 6, p. 3756, doi. 10.1093/rheumatology/keaf046

By:

Xing, Xiaoyan;
Li, Yuhui;
Liu, Qinghong;
Wang, Naidi;
Zhang, Kai;
Mo, Wanxing;
Zhao, Liang;
Zhang, Jian;
Ma, Ke;
Zhao, Xuyang;
Lu, Dan;
He, Jing

Publication type:

Article

Manubriosternal joint destruction with a rheumatoid nodule in rheumatoid arthritis.

Published in:

2025

By:

Zoshima, Takeshi

Publication type:

Case Study

Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study Open Access.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 2432, doi. 10.1093/rheumatology/keae607

By:

Russell, Mark D;
Yang, Zijing;
Dooley, Niamh;
Gibson, Mark;
Zuckerman, Benjamin;
Adas, Maryam A;
Alveyn, Edward;
Patel, Samir;
Bechman, Katie;
Price, Elizabeth;
Gallagher, Sarah;
Coalwood, Callum;
Cope, Andrew P;
Norton, Sam;
Galloway, James B

Publication type:

Article